• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 E 对非酒精性脂肪性肝病氧化还原生物标志物的影响。

Impact of vitamin E on redox biomarkers in non-alcoholic fatty liver disease.

机构信息

Department of Food Biofunctionality, Institute of Nutritional Sciences, University of Hohenheim, Germany.

Department of Food Biofunctionality, Institute of Nutritional Sciences, University of Hohenheim, Germany.

出版信息

Redox Biol. 2021 Jun;42:101937. doi: 10.1016/j.redox.2021.101937. Epub 2021 Mar 6.

DOI:10.1016/j.redox.2021.101937
PMID:33773953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8113042/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in Western nations and characterized by excessive accumulation of lipids in the liver. In this narrative review, we summarize the evidence from human trials that free radical-induced oxidation of macromolecules, in particular of lipids, is a characteristic feature of NAFLD and non-alcoholic steatohepatitis (NASH). We further synthesize the data in the scientific literature describing the impact of vitamin E (mainly α-tocopherol) on concentrations of redox biomarkers in liver biopsies from patients with NAFLD as well as animal experiments. In summary, the available evidence from clinical trials suggests that reactive species-mediated damage to macromolecules, predominantly lipids, occurs in NAFLD and NASH and that daily supplementation with at least 200 I.U. α-tocopherol may alleviate oxidative stress in the liver of NAFLD patients. We propose α-tocopherol as a useful model substance to identify and validate suitable redox biomarkers that may be employed in future clinical trials of new therapeutics for NAFLD.

摘要

非酒精性脂肪性肝病 (NAFLD) 是西方国家最常见的肝脏疾病,其特征是肝脏内脂质过度积聚。在这篇叙述性综述中,我们总结了来自人体试验的证据,即自由基诱导的大分子氧化,特别是脂质氧化,是 NAFLD 和非酒精性脂肪性肝炎 (NASH) 的一个特征。我们进一步综合了科学文献中的数据,描述了维生素 E(主要是α-生育酚)对 NAFLD 患者肝活检中氧化还原生物标志物浓度以及动物实验的影响。总之,来自临床试验的现有证据表明,活性物质介导的主要是脂质的大分子损伤发生在 NAFLD 和 NASH 中,每天补充至少 200IUα-生育酚可能缓解 NAFLD 患者肝脏的氧化应激。我们提出α-生育酚作为一种有用的模型物质,以鉴定和验证合适的氧化还原生物标志物,这些标志物可能用于未来 NAFLD 新疗法的临床试验。

相似文献

1
Impact of vitamin E on redox biomarkers in non-alcoholic fatty liver disease.维生素 E 对非酒精性脂肪性肝病氧化还原生物标志物的影响。
Redox Biol. 2021 Jun;42:101937. doi: 10.1016/j.redox.2021.101937. Epub 2021 Mar 6.
2
Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病临床及实验模型中的氧化应激与抗氧化生物标志物
Medicina (Kaunas). 2019 Jan 24;55(2):26. doi: 10.3390/medicina55020026.
3
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的脂质组学生物标志物和脂毒性机制。
Free Radic Biol Med. 2019 Nov 20;144:293-309. doi: 10.1016/j.freeradbiomed.2019.05.029. Epub 2019 May 29.
4
Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.补充维生素E对非酒精性脂肪性肝病、非酒精性脂肪性肝炎和慢性丙型肝炎患者转氨酶水平的影响:一项荟萃分析的结果
Nutrition. 2014 Sep;30(9):986-91. doi: 10.1016/j.nut.2014.01.016. Epub 2014 Feb 20.
5
Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite α-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjects.血浆中脂氧自由基衍生的维生素 E 代谢产物α-生育醌水平升高是脂肪肝患者发生脂毒性的早期指标。
Free Radic Biol Med. 2019 Feb 1;131:115-125. doi: 10.1016/j.freeradbiomed.2018.11.036. Epub 2018 Nov 30.
6
Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.系统评价与荟萃分析:维生素 E 补充剂对非酒精性脂肪性肝病成年患者的影响。
J Gastroenterol Hepatol. 2021 Feb;36(2):311-319. doi: 10.1111/jgh.15221. Epub 2020 Sep 10.
7
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.非酒精性脂肪性肝炎发病机制中的脂质氧化产物。
Free Radic Biol Med. 2017 Oct;111:173-185. doi: 10.1016/j.freeradbiomed.2017.01.023. Epub 2017 Jan 18.
8
Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD).氧化还原平衡和非酒精性脂肪性肝病 (NAFLD) 的表观遗传学。
Curr Pharm Des. 2013;19(15):2737-46. doi: 10.2174/1381612811319150009.
9
Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis.对非酒精性脂肪性肝病(NAFLD)患者进行维生素E治疗表明,氧化应激通过上调从头脂肪生成来驱动脂肪变性。
Redox Biol. 2020 Oct;37:101710. doi: 10.1016/j.redox.2020.101710. Epub 2020 Sep 1.
10
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress.非酒精性脂肪性肝病发病机制的新见解:肠道来源的脂多糖和氧化应激。
Nutrients. 2020 Sep 10;12(9):2762. doi: 10.3390/nu12092762.

引用本文的文献

1
Nutraceutical Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Path to Liver Health.代谢功能障碍相关脂肪性肝病(MASLD)的营养治疗策略:通往肝脏健康之路
Nutrients. 2025 May 13;17(10):1657. doi: 10.3390/nu17101657.
2
Targeting Metabolism: Innovative Therapies for MASLD Unveiled.靶向代谢:非酒精性脂肪性肝炎的创新疗法揭秘。
Int J Mol Sci. 2025 Apr 25;26(9):4077. doi: 10.3390/ijms26094077.
3
Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease.

本文引用的文献

1
Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis.对非酒精性脂肪性肝病(NAFLD)患者进行维生素E治疗表明,氧化应激通过上调从头脂肪生成来驱动脂肪变性。
Redox Biol. 2020 Oct;37:101710. doi: 10.1016/j.redox.2020.101710. Epub 2020 Sep 1.
2
4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept.4-HNE 免疫组化和图像分析用于检测维生素 E 治疗非酒精性脂肪性肝病(NAFLD)患者肝组织中脂质过氧化的概念验证
J Histochem Cytochem. 2020 Sep;68(9):635-643. doi: 10.1369/0022155420946402.
3
营养、饮食策略、运动、生活方式及环境对非酒精性脂肪性肝病的预防作用。
Ann Med. 2025 Dec;57(1):2464223. doi: 10.1080/07853890.2025.2464223. Epub 2025 Feb 12.
4
Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review.代谢功能障碍相关脂肪性肝病引起的抗氧化系统变化:综述
Arch Toxicol. 2025 Jan;99(1):1-22. doi: 10.1007/s00204-024-03889-x. Epub 2024 Oct 23.
5
Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?氧化应激作为非酒精性脂肪性肝病非药物干预的靶点:特级初榨橄榄油能发挥作用吗?
Antioxidants (Basel). 2024 Jun 16;13(6):731. doi: 10.3390/antiox13060731.
6
Supplementation of Micro- and Macronutrients-A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease.微量和宏量营养素的补充-营养状况在非酒精性脂肪性肝病中的作用。
Int J Mol Sci. 2024 Apr 30;25(9):4916. doi: 10.3390/ijms25094916.
7
The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review.脂肪酸ω羟化酶基因(CYP4 家族)在代谢功能障碍相关脂肪性肝病(MASLD)进展中的作用:RNA 序列数据库分析和综述。
Biochem Pharmacol. 2024 Oct;228:116241. doi: 10.1016/j.bcp.2024.116241. Epub 2024 May 1.
8
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective.从代谢角度审视MAFLD的发病机制及天然产物的药用特性。
Metabolites. 2024 Apr 12;14(4):218. doi: 10.3390/metabo14040218.
9
Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease.代谢相关性脂肪性肝病的治疗策略。
Medicina (Kaunas). 2023 Oct 8;59(10):1789. doi: 10.3390/medicina59101789.
10
Vitamin E and Pioglitazone: A Comprehensive Systematic Review of Their Efficacy in Non-alcoholic Fatty Liver Disease.维生素E与吡格列酮:关于它们在非酒精性脂肪性肝病中疗效的全面系统评价
Cureus. 2023 Aug 17;15(8):e43635. doi: 10.7759/cureus.43635. eCollection 2023 Aug.
Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
系统评价与荟萃分析:维生素 E 补充剂对非酒精性脂肪性肝病成年患者的影响。
J Gastroenterol Hepatol. 2021 Feb;36(2):311-319. doi: 10.1111/jgh.15221. Epub 2020 Sep 10.
4
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade.非酒精性脂肪性肝病的多重平行打击假说:十年后再审视
Hepatology. 2021 Feb;73(2):833-842. doi: 10.1002/hep.31518. Epub 2021 Feb 6.
5
Non-alcoholic fatty liver disease and childhood obesity.非酒精性脂肪性肝病与儿童肥胖。
Arch Dis Child. 2021 Jan;106(1):3-8. doi: 10.1136/archdischild-2019-318063. Epub 2020 May 14.
6
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.氧化应激在非酒精性脂肪性肝病发病机制中的作用。
Free Radic Biol Med. 2020 May 20;152:116-141. doi: 10.1016/j.freeradbiomed.2020.02.025. Epub 2020 Mar 8.
7
Vitamin E sequestration by liver fat in humans.维生素 E 被人体肝脏脂肪隔离。
JCI Insight. 2020 Jan 16;5(1):133309. doi: 10.1172/jci.insight.133309.
8
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.组织学疾病活动与非酒精性脂肪性肝病进展的关联。
JAMA Netw Open. 2019 Oct 2;2(10):e1912565. doi: 10.1001/jamanetworkopen.2019.12565.
9
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.维生素 E 对 2 型糖尿病非酒精性脂肪性肝炎患者的作用:一项随机对照试验。
Diabetes Care. 2019 Aug;42(8):1481-1488. doi: 10.2337/dc19-0167. Epub 2019 May 21.
10
Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients.非酒精性脂肪性肝病 (NAFLD) 患者血清和血浆中的氧化应激生物标志物。血浆 AGE 可以作为 NAFLD 的标志物吗?NAFLD 患者的氧化应激生物标志物。
Free Radic Res. 2019 Aug;53(8):841-850. doi: 10.1080/10715762.2019.1635691. Epub 2019 Jul 8.